These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 22105781)

  • 1. Pulmonary arterial hypertension associated with systemic sclerosis in the Czech Republic.
    Jansa P; Becvar R; Ambroz D; Palecek T; Tomcik M; Skacelova S; Aschermann M; Linhart A
    Clin Rheumatol; 2012 Mar; 31(3):557-61. PubMed ID: 22105781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohorts.
    Gladue H; Steen V; Allanore Y; Saggar R; Saggar R; Maranian P; Berrocal VJ; Avouac J; Meune C; Trivedi M; Khanna D
    J Rheumatol; 2013 Oct; 40(10):1706-11. PubMed ID: 23950183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the DETECT algorithm for detection of risk of pulmonary arterial hypertension in systemic sclerosis: data from a Czech tertiary centre.
    Soukup T; Pudil R; Kubinova K; Hromadkova L; Dusek J; Tosovsky M; Bradna P; Hrncir Z; Bures J
    Rheumatology (Oxford); 2016 Jan; 55(1):109-14. PubMed ID: 26320140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry.
    Bae S; Saggar R; Bolster MB; Chung L; Csuka ME; Derk C; Domsic R; Fischer A; Frech T; Goldberg A; Hinchcliff M; Hsu V; Hummers L; Schiopu E; Mayes MD; McLaughlin V; Molitor J; Naz N; Furst DE; Maranian P; Steen V; Khanna D
    Ann Rheum Dis; 2012 Aug; 71(8):1335-42. PubMed ID: 22307943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment for Pulmonary Artery Hypertension Using Clinical and Echocardiographic Criteria in Patients With Systemic Sclerosis.
    Methia N; Latreche S; Ait Mokhtar O; Monsuez JJ; Benkhedda S
    Am J Med Sci; 2016 Oct; 352(4):343-347. PubMed ID: 27776714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
    Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R
    Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up.
    Vilela VS; Dias MM; Salgado ÂA; da Silva BRA; Lopes AJ; Bessa EJC; Bruno LP; da Costa CH; Levy RA; Rufino R
    BMC Pulm Med; 2021 Jul; 21(1):251. PubMed ID: 34325685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France.
    Hachulla E; de Groote P; Gressin V; Sibilia J; Diot E; Carpentier P; Mouthon L; Hatron PY; Jego P; Allanore Y; Tiev KP; Agard C; Cosnes A; Cirstea D; Constans J; Farge D; Viallard JF; Harle JR; Patat F; Imbert B; Kahan A; Cabane J; Clerson P; Guillevin L; Humbert M;
    Arthritis Rheum; 2009 Jun; 60(6):1831-9. PubMed ID: 19479881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension.
    Corrado A; Correale M; Mansueto N; Monaco I; Carriero A; Mele A; Colia R; Di Biase M; Cantatore FP
    Microvasc Res; 2017 Nov; 114():46-51. PubMed ID: 28619664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the necessity for right heart catheterization in pulmonary hypertension associated with connective tissue diseases assessed by echocardiography.
    Choi JH; Joo SJ; Kim J
    Int J Rheum Dis; 2016 Jan; 19(1):65-73. PubMed ID: 26820839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of pulmonary hypertension in systemic sclerosis.
    de Azevedo AB; Sampaio-Barros PD; Torres RM; Moreira C
    Clin Exp Rheumatol; 2005; 23(4):447-54. PubMed ID: 16095111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.
    Argula RG; Karwa A; Lauer A; Gregg D; Silver RM; Feghali-Bostwick C; Schanpp LM; Egbert K; Usher BW; Ramakrishnan V; Hassoun PM; Strange C
    Ann Am Thorac Soc; 2017 May; 14(5):682-689. PubMed ID: 28282243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
    Thakkar V; Stevens WM; Prior D; Moore OA; Byron J; Liew D; Patterson K; Hissaria P; Roddy J; Zochling J; Sahhar J; Nash P; Tymms K; Celermajer D; Gabbay E; Youssef P; Proudman SM; Nikpour M
    Arthritis Res Ther; 2012 Jun; 14(3):R143. PubMed ID: 22691291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.
    Coghlan JG; Denton CP; Grünig E; Bonderman D; Distler O; Khanna D; Müller-Ladner U; Pope JE; Vonk MC; Doelberg M; Chadha-Boreham H; Heinzl H; Rosenberg DM; McLaughlin VV; Seibold JR;
    Ann Rheum Dis; 2014 Jul; 73(7):1340-9. PubMed ID: 23687283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening of pulmonary hypertension in a Spanish cohort of patients with systemic sclerosis].
    García Hernández FJ; Castillo Palma MJ; Montero Mateos E; González León R; López Haldón JE; Sánchez Román J
    Med Clin (Barc); 2016 Jan; 146(1):1-7. PubMed ID: 26169331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se.
    Lindholm A; Hesselstrand R; Rådegran G; Arheden H; Ostenfeld E
    Clin Physiol Funct Imaging; 2019 May; 39(3):215-225. PubMed ID: 30597705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis.
    Hao Y; Thakkar V; Stevens W; Morrisroe K; Prior D; Rabusa C; Youssef P; Gabbay E; Roddy J; Walker J; Zochling J; Sahhar J; Nash P; Lester S; Rischmueller M; Proudman SM; Nikpour M
    Arthritis Res Ther; 2015 Jan; 17(1):7. PubMed ID: 25596924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
    Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
    Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis.
    Pope JE; Lee P; Baron M; Dunne J; Smith D; Docherty PS; Bookman A; Abu-Hakima M
    J Rheumatol; 2005 Jul; 32(7):1273-8. PubMed ID: 15996064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced diffusing capacity for carbon monoxide predicts borderline pulmonary arterial pressure in patients with systemic sclerosis.
    Ninagawa K; Kato M; Nakamura H; Abe N; Kono M; Fujieda Y; Oku K; Yasuda S; Ohira H; Tsujino I; Atsumi T
    Rheumatol Int; 2019 Nov; 39(11):1883-1887. PubMed ID: 31280357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.